Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Peripheral Primitive Neuroectodermal Tumor of Soft Tissue clinical trials
1 of 1 indexed Peripheral Primitive Neuroectodermal Tumor of Soft Tissue trials are currently recruiting.
Corpus placement: #11,370 of 28,707 conditions by registered trial count.
1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count
Peripheral Primitive Neuroectodermal Tumor of Soft Tissue: 1 US clinical trial tracked, 1 recruiting.
Peripheral Primitive Neuroectodermal Tumor of Soft Tissue is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Dana-Farber Cancer Institute, running 1 of these trials.
Enrollment posture brief
Registry condition peripheral-primitive-neuroectodermal-tumor-of-soft-tissue
OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Peripheral Primitive Neuroectodermal Tumor of Soft Tissue lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Peripheral Primitive Neuroectodermal Tumor of Soft Tissue on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Peripheral Primitive Neuroectodermal Tumor of Soft Tissue is recruiting above its size-band peers.
1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
1 total, page 1 of 1
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Peripheral Primitive Neuroectodermal Tumor of Soft Tissue records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Peripheral Primitive Neuroectodermal Tumor of Soft Tissue trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Peripheral Primitive Neuroectodermal Tumor of Soft Tissue page
1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Peripheral Primitive Neuroectodermal Tumor of Soft Tissue trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Dana-Farber Cancer Institute sponsors the most Peripheral Primitive Neuroectodermal Tumor of Soft Tissue trials on record, review their full trial history before evaluating a specific study. See Dana-Farber Cancer Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Peripheral Primitive Neuroectodermal Tumor of Soft Tissue condition card totals 1 registered trials; most-linked intervention FoundationOne Liquid CDx; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.